9 May 2025 -- Hamburg, Germany and Colorado, US -- Think Bioscience, a small molecule discovery company that leverages synthetic biology to find novel binding pockets on challenging drug targets, and CrystalsFirst, a leader in structure-based drug discovery solutions, today announced that their ongoing collaboration has led to the identification of novel mechanisms of action for several difficult targets in Think Bioscience’s pipeline.

7 May 2025 -- Oxford, UK -- Refeyn, the company behind pioneering mass photometry technology, has announced the installation of the 500th system based on its novel single-particle bioanalytical technology – notably, within just seven years of its spin out from Oxford University in 2018.

7 May 2025 -- Cambridge, UK -- ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, has revealed the keynote speakers for its flagship event, Drug Discovery 2025. Taking place at the ACC in Liverpool, UK from 21–22 October, the conference will feature presentations from Professor Heather Pinkett (Northwestern University) and Dr Dafydd Owen (Pfizer Medicine Design).

7 May 2025 — California, US and Düsseldorf, Germany — Bionova Scientific, an Asahi Kasei boutique commercial-scale biologics contract development and manufacturing organization (CDMO), today announced it has licensed ATUM’s proprietary Leap-In Transposase® transposon-based gene delivery and its miCHO™ cell line development technologies.

7 May 2025 -- GDAŃSK, Poland and BERLIN, Germany -- ProBioGen announced today an agreement with Polpharma Biologics, an international biotech company dedicated to the development and manufacture of biosimilars. Under this agreement ProBioGen will conduct high-performance cell line development services for Polpharma's biosimilar candidate, supporting their expanding pipeline.

6 May 2025 -- Valby, Denmark -- H. Lundbeck A/S is pleased to announce its agreement with the Danish Centre for AI Innovation (DCAI), the company established to run and operate Gefion, Denmark’s flagship AI supercomputer. Lundbeck is one of the first pharmaceutical companies to leverage Gefion to accelerate drug discovery and development in neurological and psychiatric disorders.

6 May 2025 -- Nebraska, US -- Celerion, a global leader in early clinical research and bioanalytical services, announced the launch of the latest version of Labnotes, its cutting-edge bioanalytical electronic laboratory notebook software elevating data handling and analysis capabilities for sponsors.

6 May 2025 -- California, US -- Trilobio, the Company building the fully automated robotic lab-in-a-box for biologists, today announced it has raised $8 million USD Seed investment. The oversubscribed round was led by Initialized Capital, including participation from Argon Ventures and Lowercarbon Capital.

1 May 2025 -- Ontario, Canada -- Alimentiv and Dova Health Intelligence™ (formerly Satisfai Health) are announcing the commercial availability of Dova Health’s DovaVision™, an AI-powered dynamic frame-level Mayo Endoscopic Sub-score (MES) feature analysis solution of endoscopy videos, providing adjunct AI-reads for Phase I through IV UC clinical trials.

25 April 2025 -- Durham, NC and Männedorf, Switzerland -- BioSkryb Genomics and Tecan Group today introduced a high-throughput single-cell workflow, combining BioSkryb’s 384-well format of the ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit with the Uno Single Cell Dispenser™, provided by Tecan.

24 April 2025 -- Eschborn, Germany -- AnalytiChem, manufacturer of specialized laboratory equipment, reagents and consumables, has introduced Redipor ready-to-use culture media as an AnalytiChem branded product line globally.

22 April 2025 -- Bubendorf, Switzerland -- CARBOGEN AMCIS, a Switzerland-based pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, is pleased to announce that its Shanghai facility has successfully obtained its first Drug Manufacturing License (DML) from China’s National Medical Products Administration (NMPA).